Charles Greg Guyer - Apr 29, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Technical Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Apr 29, 2022
Transactions value $
-$317,171
Form type
4
Date filed
5/6/2022, 08:19 PM
Previous filing
Mar 17, 2022
Next filing
Aug 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $15.2K +243 +0.47% $62.41 52.3K Apr 29, 2022 Direct F1
transaction BMRN Common Stock Tax liability -$332K -3.93K -7.51% $84.65 48.4K May 4, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan.